Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Low HDL-C”

31 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 31 results

Not applicableStudy completedNCT01690312
What this trial is testing

Clinical Study to Assess High-DHA Fish Oil on Biomarkers of Cardiovascular Disease Risk in Adults on Statin Therapy

Who this might be right for
Cardiovascular Disease
Nutrasource Pharmaceutical and Nutraceutical Services, Inc. 36
Post-approval studies (Phase 4)Ended earlyNCT01025492
What this trial is testing

Study of Trilipix Effects on Lipids and Arteries

Who this might be right for
Dyslipidemia
University of Utah 24
Testing effectiveness (Phase 2)Study completedNCT00327002
What this trial is testing

A Mechanistic Study of the Effects of LY518674 on High-Density Lipoprotein Cholesterol (HDL-C) Metabolism

Who this might be right for
Metabolic Syndrome X
University of Pennsylvania 40
Testing effectiveness (Phase 2)Study completedNCT01423188
What this trial is testing

The Study of Quantitative Serial Trends in Lipids With ApolpoproteinA-I Stimulation

Who this might be right for
Coronary Artery DiseaseDyslipidemia
Resverlogix Corp 176
Large-scale testing (Phase 3)Study completedNCT05888103
What this trial is testing

Efficacy and Safety of Inclisiran as Monotherapy in Chinese Adults With Low or Moderate ASCVD Risk and Elevated Low-density Lipoprotein Cholesterol.

Who this might be right for
Primary Hypercholesterolemia or Mixed Dyslipidemia
Novartis Pharmaceuticals 207
Early research (Phase 1)Study completedNCT01618916
What this trial is testing

LY3015014 in Otherwise Healthy Participants With High Low-density Lipoprotein (LDL) Cholesterol

Who this might be right for
Healthy Volunteers
Eli Lilly and Company 51
Testing effectiveness (Phase 2)Study completedNCT02585869
What this trial is testing

Efficacy and Safety of Gemcabene in Patients With Low HDL-C and Either Normal or Elevated Triglycerides

Who this might be right for
HypercholesterolemiaHypertriglyceridemia
NeuroBo Pharmaceuticals Inc. 161
Post-approval studies (Phase 4)UnknownNCT00736463
What this trial is testing

Crossover of Higher Dose Statins in Patients With Low High-density Lipoproteins Cholesterol (HDLc)

Who this might be right for
HDL Cholesterol
Oregon Health and Science University 80
Large-scale testing (Phase 3)Study completedNCT01860729
What this trial is testing

The Safety and Efficacy of Anacetrapib (MK-0859) Among Participants With Hypercholesterolemia When Added to Ongoing Statin Therapy (MK-0859-022)

Who this might be right for
Hypercholesterolemia
Merck Sharp & Dohme LLC 589
Testing effectiveness (Phase 2)Study completedNCT00748852
What this trial is testing

Safety Study of JTT-302 in Subjects With Low HDL-C Levels

Who this might be right for
Dyslipidemia
Akros Pharma Inc. 103
Large-scale testing (Phase 3)Study completedNCT00389896
What this trial is testing

A Crossover Study to Evaluate the Efficacy of Simvastatin in Elevating HDL-C Levels in Patients With Type 2 Diabetes (0733-216)(COMPLETED)

Who this might be right for
HDL Cholesterol
Organon and Co 150
Early research (Phase 1)Study completedNCT01448824
What this trial is testing

LY2484595 on Pharmacokinetics in Healthy Participants

Who this might be right for
Healthy Participants
Eli Lilly and Company 82
Large-scale testing (Phase 3)Study completedNCT05079919
What this trial is testing

Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia

Who this might be right for
Severe Hypertriglyceridemia
Ionis Pharmaceuticals, Inc. 617
Not applicableStudy completedNCT00931320
What this trial is testing

Investigation Into the RAtio of LDL-CHolestEroL to HDL-Cholesterol Improvement After Statin Treatment in Korean Patients

Who this might be right for
Dyslipidemias
AstraZeneca 3,000
Large-scale testing (Phase 3)Ended earlyNCT01414166
What this trial is testing

Niacin/Laropiprant Tablet for South and Southeast Asians With Low High-Density Lipoprotein Cholesterol (LDL-C) at Risk for Cardiovascular Disease (MK-0524A-108)

Who this might be right for
Dyslipidemia
Merck Sharp & Dohme LLC 244
Not applicableStudy completedNCT01245738
What this trial is testing

Effect of Statins on Lipid Levels Following the First Acute Coronary Event (MK-0000-204)

Who this might be right for
DyslipidemiasHypercholesterolemiaHypertriglyceridemia+2 more
Merck Sharp & Dohme LLC 635
Post-approval studies (Phase 4)Ended earlyNCT01308203
What this trial is testing

Lipid Efficacy of the Extended Release Niacin/Laropiprant Combination in Patients With Cardiovascular Disease

Who this might be right for
Coronary Artery DiseaseDyslipidemias
Daniel A. Siniawski 32
Large-scale testing (Phase 3)Study completedNCT01717300
What this trial is testing

The Safety and Efficacy of Anacetrapib (MK-0859) When Added to Ongoing Statin Therapy (MK-0859-021)

Who this might be right for
Hypercholesterolemia
Merck Sharp & Dohme LLC 459
Not applicableEnded earlyNCT00525083
What this trial is testing

Protein and Phospholipid Analysis of HDL in Patients With Very High Serum Levels of HDL-C

Who this might be right for
Hyperlipidemia
Vanderbilt University Medical Center 19
Testing effectiveness (Phase 2)Study completedNCT01105975
What this trial is testing

LY2484595 in Patients With High LDL-C or Low HDL-C

Who this might be right for
Dyslipidemia
Eli Lilly and Company 398
Load More Results